These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 27573470)
1. Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice. Wang Y; Liu LM; Wei L; Ye WW; Meng XY; Chen F; Xiao Q; Chen JY; Zhou Y Mol Med Rep; 2016 Oct; 14(4):3293-300. PubMed ID: 27573470 [TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
3. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity. Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956 [TBL] [Abstract][Full Text] [Related]
12. Mulberry ethanol extract attenuates hepatic steatosis and insulin resistance in high-fat diet-fed mice. Song H; Lai J; Tang Q; Zheng X Nutr Res; 2016 Jul; 36(7):710-8. PubMed ID: 27262537 [TBL] [Abstract][Full Text] [Related]
13. The C-terminal fibrinogen-like domain of angiopoietin-like 4 stimulates adipose tissue lipolysis and promotes energy expenditure. McQueen AE; Kanamaluru D; Yan K; Gray NE; Wu L; Li ML; Chang A; Hasan A; Stifler D; Koliwad SK; Wang JC J Biol Chem; 2017 Sep; 292(39):16122-16134. PubMed ID: 28842503 [TBL] [Abstract][Full Text] [Related]
14. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929 [TBL] [Abstract][Full Text] [Related]
15. Trans-Fatty Acids Aggravate Obesity, Insulin Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1 Dependent Pathway. Zhao X; Shen C; Zhu H; Wang C; Liu X; Sun X; Han S; Wang P; Dong Z; Ma X; Hu K; Sun A; Ge J Molecules; 2016 May; 21(6):. PubMed ID: 27248994 [TBL] [Abstract][Full Text] [Related]
16. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling. Yao Y Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448 [TBL] [Abstract][Full Text] [Related]
17. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota. Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266 [TBL] [Abstract][Full Text] [Related]
18. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice. Gao M; Bu L; Ma Y; Liu D PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402 [TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models. Kim MK; Chae YN; Ahn GJ; Shin CY; Choi SH; Yang EK; Sohn YS; Son MH Arch Pharm Res; 2017 Feb; 40(2):268-281. PubMed ID: 27885461 [TBL] [Abstract][Full Text] [Related]
20. [Effect of ginsenoside Rb1 in ameliorating insulin resistance and ectopic fat deposition in obese mice induced by high fat diet]. Shang WB; Yu XZ; Wang GQ; Zhao J Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4119-23. PubMed ID: 24791501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]